News
12 Health Care Stocks Moving In Friday's Pre-Market Session
22 Mar 24
Movers
Eton Pharmaceuticals Acquires Exclusive U.S. Rights To PKU GOLIKE® From Relief Therapeutics, Expects To Be Accretive To Earnings In 2024
22 Mar 24
M&A, News
Recap: Eton Pharmaceuticals Q4 Earnings
14 Mar 24
Earnings
Eton Pharmaceuticals Q4 2023 GAAP EPS $(0.09) Misses $(0.04) Estimate, Sales $7.313M Miss $7.700M Estimate
14 Mar 24
Earnings, Earnings Misses, News
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
Eton Pharmaceuticals Earnings Preview
13 Mar 24
Earnings
Eton Pharmaceuticals Won US Patent for Proprietary Hydrocortisone Oral Liquid Formulation
21 Feb 24
Government, News, Regulations
Press releases
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
22 Mar 24
News, Press Releases
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
22 Mar 24
M&A, News, Press Releases
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 24
Earnings, Press Releases
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
29 Feb 24
News, Press Releases
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
21 Feb 24
Press Releases
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
2 Feb 24
Health Care, Press Releases, General